US5702359A
(en)
*
|
1995-06-06 |
1997-12-30 |
Genetronics, Inc. |
Needle electrodes for mediated delivery of drugs and genes
|
US5993434A
(en)
*
|
1993-04-01 |
1999-11-30 |
Genetronics, Inc. |
Method of treatment using electroporation mediated delivery of drugs and genes
|
US6261281B1
(en)
*
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
KR20010020570A
(ko)
*
|
1997-06-30 |
2001-03-15 |
자끄 사비나 |
다세포 진핵 생물 세포중으로 개선된 핵산 전달방법 및이를 위한 콤비네이션
|
DE69826124T3
(de)
*
|
1997-06-30 |
2007-10-11 |
Institut Gustave Roussy |
Verabreichung der nukleinsäure in den quergestreiften muskel
|
US6055453A
(en)
|
1997-08-01 |
2000-04-25 |
Genetronics, Inc. |
Apparatus for addressing needle array electrodes for electroporation therapy
|
US6241701B1
(en)
|
1997-08-01 |
2001-06-05 |
Genetronics, Inc. |
Apparatus for electroporation mediated delivery of drugs and genes
|
US20040229363A1
(en)
*
|
1998-06-24 |
2004-11-18 |
Ed Nolan |
High efficiency transfection based on low electric field strength, long pulse length
|
US6678556B1
(en)
|
1998-07-13 |
2004-01-13 |
Genetronics, Inc. |
Electrical field therapy with reduced histopathological change in muscle
|
EP2428249B1
(de)
|
1998-07-13 |
2015-10-07 |
Inovio Pharmaceuticals, Inc. |
Haut- und muskelgerichtete Gentherapie mithilfe eines gepulsten elektrischen Felds
|
US7922709B2
(en)
|
1998-07-13 |
2011-04-12 |
Genetronics, Inc. |
Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
|
CA2361601A1
(en)
*
|
1999-02-08 |
2000-08-10 |
Cheryl Goldbeck |
Electrically-mediated enhancement of dna vaccine immunity and efficacy in vivo
|
US6593130B1
(en)
*
|
1999-04-16 |
2003-07-15 |
The Regents Of The University Of California |
Method and apparatus for ex vivo and in vivo cellular electroporation of gene protein or drug therapy
|
BR0108959A
(pt)
*
|
2000-03-03 |
2003-10-14 |
Valentis Inc |
Composições de poloxmero ou poloxamina melhoradas para distribuição de ácido nucléico
|
AU6475901A
(en)
|
2000-05-22 |
2001-12-03 |
Merck And Company Inc |
System and method for assessing the performance of a pharmaceutical agent delivery system
|
US6733485B1
(en)
|
2001-05-25 |
2004-05-11 |
Advanced Bionics Corporation |
Microstimulator-based electrochemotherapy methods and systems
|
US20040204669A1
(en)
*
|
2001-07-05 |
2004-10-14 |
Hofmann Gunter A. |
Apparatus for electroporation mediated delivery for drugs and genes
|
US7713740B2
(en)
*
|
2001-08-24 |
2010-05-11 |
University Of South Florida |
Method of using electric fields to facilitate the entry of molecules into cells in vivo
|
CA2461380C
(en)
|
2001-10-11 |
2011-03-22 |
Merck & Co., Inc. |
Hepatitis c virus vaccine
|
EP2172552A3
(de)
|
2001-10-11 |
2010-07-21 |
Merck Sharp & Dohme Corp. |
Rekombinante Nukleinsäuren beinhaltend Regionen von AD6
|
IL161862A0
(en)
*
|
2001-11-08 |
2005-11-20 |
Univ California |
Methods and compositions for correction of cardiac conduction disturbances
|
CN1638780A
(zh)
*
|
2001-12-14 |
2005-07-13 |
遗传电子公司 |
用脉冲电场进行颗粒辅助的多核苷酸免疫的方法
|
KR20040099264A
(ko)
*
|
2002-01-18 |
2004-11-26 |
이노비오 에이에스 |
근육내 투여를 위한 이중특이성 항체 dna 작제물
|
US8209006B2
(en)
|
2002-03-07 |
2012-06-26 |
Vgx Pharmaceuticals, Inc. |
Constant current electroporation device and methods of use
|
US7245963B2
(en)
*
|
2002-03-07 |
2007-07-17 |
Advisys, Inc. |
Electrode assembly for constant-current electroporation and use
|
JP2005518904A
(ja)
|
2002-03-07 |
2005-06-30 |
マーク アンド カンパニー インコーポレイテッド |
電気的刺激の側面を備えた臨床用注射器
|
US6912417B1
(en)
*
|
2002-04-05 |
2005-06-28 |
Ichor Medical Systmes, Inc. |
Method and apparatus for delivery of therapeutic agents
|
JP4499427B2
(ja)
|
2002-04-16 |
2010-07-07 |
サイト パルス サイエンシズ、インコーポレイテッド |
電場の移動及び電極極性の反転で生体材料を処理する方法。
|
US20040106896A1
(en)
*
|
2002-11-29 |
2004-06-03 |
The Regents Of The University Of California |
System and method for forming a non-ablative cardiac conduction block
|
US7328064B2
(en)
|
2002-07-04 |
2008-02-05 |
Inovio As |
Electroporation device and injection apparatus
|
EP3466483A1
(de)
|
2004-03-08 |
2019-04-10 |
Ichor Medical Systems Inc. |
Verbessertes gerät für die elektrisch vermittelte abgabe von therapeutika
|
TW200613554A
(en)
|
2004-06-17 |
2006-05-01 |
Wyeth Corp |
Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV
|
JP2008532560A
(ja)
*
|
2005-03-19 |
2008-08-21 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
微弱電界ネットワークを仲介して行う、生体外で細胞内に遺伝子、タンパク質および薬剤を送達する方法および装置
|
EP1893636A2
(de)
|
2005-06-17 |
2008-03-05 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Hepatitis-c-virus-nukleinsäureimpfstoff
|
AU2007215328A1
(en)
*
|
2006-02-13 |
2007-08-23 |
Oncolytics Biotech Inc. |
Use of local immune suppression to enhance oncolytic viral therapy
|
JP5646851B2
(ja)
|
2006-11-17 |
2014-12-24 |
ジェネトロニクス,インコーポレイティド |
エレクトロポレーション支援ワクチン投与及び追加投与を用いた免疫応答の増強方法
|
PL2612868T3
(pl)
|
2007-11-01 |
2018-12-31 |
Astellas Pharma Inc. |
Immunosupresyjne polipeptydy i kwasy nukleinowe
|
AU2009231598B2
(en)
|
2008-04-04 |
2015-03-12 |
The Trustees Of The University Of Pennsylvania |
Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the same
|
WO2009124312A2
(en)
*
|
2008-04-04 |
2009-10-08 |
The Trustees Of The University Of Pennsylvania |
Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same
|
EP2147697A1
(de)
|
2008-07-21 |
2010-01-27 |
Centre National De La Recherche Scientifique-CNRS |
Verfahren und Vorrichtung zur Anwendung elektrischer Felder in leitfähiges Material
|
EP2156860A1
(de)
|
2008-08-20 |
2010-02-24 |
Centre National De La Recherche Scientifique-CNRS |
Verfahren zur Herstellung isolierter Elektroden zum Einfügen elektrischer Felder in ein leitfähiges Material
|
US20100298697A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Medtronic, Inc. |
Method and devices for improved efficiency of rna delivery to cells
|
US8207138B2
(en)
|
2009-05-19 |
2012-06-26 |
Medtronic, Inc. |
Methods and devices for improved efficiency of RNA delivery to cells
|
WO2011032179A1
(en)
|
2009-09-14 |
2011-03-17 |
The Trustees Of The University Of Pennsylvania |
Vaccines and immunotherapeutics comprising il-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same
|
KR101965337B1
(ko)
|
2009-11-02 |
2019-04-03 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
구제역 바이러스(fmdv) 공통 단백질, 이를 위한 코딩 서열 및 이로부터 만들어진 백신
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
WO2011097640A1
(en)
|
2010-02-08 |
2011-08-11 |
The Trustees Of The University Of Pennsylvania |
Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same
|
JP6293485B2
(ja)
|
2010-09-27 |
2018-03-14 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
コンセンサス抗原コンストラクトおよびそれらから作製されるワクチン、ならびにそれらを使用するマラリアの治療方法
|
SI3536703T1
(sl)
|
2010-11-12 |
2022-04-29 |
The Trustees Of The University Of Pennsylvania |
Konsenzni prostatični antigeni, molekule nukleinske kisline, ki jih kodirajo in uporabe le-teh
|
JP6099573B2
(ja)
|
2011-01-31 |
2017-03-22 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
新規なヘルペス抗原をコードする核酸分子、それを含むワクチン及びその使用方法
|
WO2012109668A1
(en)
|
2011-02-11 |
2012-08-16 |
The Trustees Of The University Of Pennsylvania |
Nucleic acid molecule encoding hepatitis b virus core protein and vaccine comprising the same
|
US9238679B2
(en)
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
EP2720740A1
(de)
|
2011-06-15 |
2014-04-23 |
ChronTech Pharma AB |
Injektionsnadel und vorrichtung
|
US9446114B2
(en)
|
2011-07-11 |
2016-09-20 |
Inovio Pharmaceuticals, Inc. |
Cross-protective arenavirus vaccines and their method of use
|
KR20220132652A
(ko)
|
2011-12-12 |
2022-09-30 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
개선된 il-12 유전적 컨스트럭트 및 백신을 포함하는 조성물, 면역치료제 및 이를 이용하는 방법
|
JP6407028B2
(ja)
|
2011-12-12 |
2018-10-17 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
MRSAのPBP2a及びその断片を含むタンパク質、それをコードする核酸、並びにMRSA感染を予防する及び治療するための組成物及びそれらの使用
|
KR20140146651A
(ko)
|
2012-04-10 |
2014-12-26 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
인간 호흡기 합포체 바이러스 공통 항원, 핵산 컨스트럭트 및 이들로부터 제조된 백신, 및 이들을 사용하는 방법
|
EP4190350A1
(de)
|
2012-04-12 |
2023-06-07 |
The Trustees Of The University Of Pennsylvania |
Filovirus-konsensusantigene, nukleinsäurekonstrukte und daraus hergestellte impfstoffe sowie verfahren zur verwendung davon
|
DE102012013534B3
(de)
|
2012-07-05 |
2013-09-19 |
Tobias Sokolowski |
Vorrichtung für repetitive Nervenstimulation zum Abbau von Fettgewebe mittels induktiver Magnetfelder
|
WO2014064534A2
(en)
|
2012-10-05 |
2014-05-01 |
Chrontech Pharma Ab |
Injection needle, device, immunogenic compositions and method of use
|
AU2013358947B2
(en)
|
2012-12-13 |
2016-10-20 |
Inovio Pharmaceuticals, Inc. |
WT1 vaccine
|
KR102276405B1
(ko)
|
2013-03-15 |
2021-07-12 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
구제역 바이러스 (fmdv) 공통 단백질, 그에 대한 코딩 서열 및 그로부터 제조된 백신
|
KR20150130284A
(ko)
|
2013-03-15 |
2015-11-23 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
암 백신 및 이를 이용한 치료 방법
|
DK3028048T3
(en)
|
2013-07-31 |
2019-01-21 |
Bioventures Llc |
COMPOSITIONS FOR TREATMENT AND PREVENTION OF CANCER TARGETING AGAINST TUMOR-ASSOCIATED CARBOHYDRATE ANTIGEN
|
CN105829341A
(zh)
|
2013-12-13 |
2016-08-03 |
宾夕法尼亚大学理事会 |
Dna抗体构建体及其使用方法
|
CN107427566B
(zh)
|
2014-12-01 |
2021-08-17 |
宾夕法尼亚大学理事会 |
Dna抗体构建体及其使用方法
|
US11491342B2
(en)
|
2015-07-01 |
2022-11-08 |
Btl Medical Solutions A.S. |
Magnetic stimulation methods and devices for therapeutic treatments
|
US10695575B1
(en)
|
2016-05-10 |
2020-06-30 |
Btl Medical Technologies S.R.O. |
Aesthetic method of biological structure treatment by magnetic field
|
US11266850B2
(en)
|
2015-07-01 |
2022-03-08 |
Btl Healthcare Technologies A.S. |
High power time varying magnetic field therapy
|
US20180001107A1
(en)
|
2016-07-01 |
2018-01-04 |
Btl Holdings Limited |
Aesthetic method of biological structure treatment by magnetic field
|
WO2017055522A1
(en)
|
2015-09-29 |
2017-04-06 |
Academisch Medisch Centrum |
Stabilized env proteins of hiv
|
US11253717B2
(en)
|
2015-10-29 |
2022-02-22 |
Btl Healthcare Technologies A.S. |
Aesthetic method of biological structure treatment by magnetic field
|
BR112018015893A2
(pt)
|
2016-02-05 |
2019-03-06 |
Inovio Pharmaceuticals Inc |
vacinas de câncer e métodos de tratamento usando as mesmas
|
KR102535764B1
(ko)
|
2016-03-28 |
2023-05-30 |
아이커 메디칼 시스템스 인코포레이티드 |
치료제를 전달하기 위한 장치
|
JP7250520B2
(ja)
|
2016-04-13 |
2023-04-03 |
ヤンセン ファーマシューティカルズ,インコーポレーテッド |
組換えアルテリウイルスレプリコン系およびその使用
|
US11247039B2
(en)
|
2016-05-03 |
2022-02-15 |
Btl Healthcare Technologies A.S. |
Device including RF source of energy and vacuum system
|
US11464993B2
(en)
|
2016-05-03 |
2022-10-11 |
Btl Healthcare Technologies A.S. |
Device including RF source of energy and vacuum system
|
US11534619B2
(en)
|
2016-05-10 |
2022-12-27 |
Btl Medical Solutions A.S. |
Aesthetic method of biological structure treatment by magnetic field
|
US10583287B2
(en)
|
2016-05-23 |
2020-03-10 |
Btl Medical Technologies S.R.O. |
Systems and methods for tissue treatment
|
US10556122B1
(en)
|
2016-07-01 |
2020-02-11 |
Btl Medical Technologies S.R.O. |
Aesthetic method of biological structure treatment by magnetic field
|
CN110073002A
(zh)
|
2016-10-17 |
2019-07-30 |
合成基因组公司 |
重组病毒复制子体系及其用途
|
WO2018106615A2
(en)
|
2016-12-05 |
2018-06-14 |
Synthetic Genomics, Inc. |
Compositions and methods for enhancing gene expression
|
EP3672983A1
(de)
|
2017-08-26 |
2020-07-01 |
Academisch Medisch Centrum |
Verbesserte hiv-hüllglykoprotein-immunogene
|
BR112020011443A2
(pt)
|
2017-12-13 |
2020-12-01 |
Inovio Pharmaceuticals, Inc. |
molécula de ácido nucleico e seu uso, vetor e seu uso, composição, proteína e vacina
|
JP7352547B2
(ja)
|
2017-12-13 |
2023-09-28 |
イノビオ ファーマシューティカルズ,インコーポレイティド |
メソセリンを標的とするがんワクチンおよびその使用
|
JP7441169B2
(ja)
|
2017-12-13 |
2024-02-29 |
イノビオ ファーマシューティカルズ,インコーポレイティド |
Muc16を標的とするがんワクチンおよびその使用
|
EA202091513A1
(ru)
|
2017-12-19 |
2020-09-09 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Вакцины против вируса гепатита b (hbv) и их применение
|
KR20200101416A
(ko)
|
2017-12-19 |
2020-08-27 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
B형 간염 바이러스(hbv) 백신 및 그 용도
|
EA202091516A1
(ru)
|
2017-12-19 |
2020-11-03 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Способы и композиции для индукции иммунного ответа против вируса гепатита b (hbv)
|
US11389531B2
(en)
|
2017-12-19 |
2022-07-19 |
Janssen Sciences Ireland Unlimited Company |
Methods and apparatus for the delivery of hepatitis B virus (HBV) vaccines
|
MA51312A
(fr)
|
2017-12-19 |
2020-10-28 |
Bavarian Nordic As |
Méthodes et compositions permettant d'induire une réponse immunitaire contre le virus de l'hépatite b (vhb)
|
US11083786B2
(en)
|
2018-01-19 |
2021-08-10 |
Janssen Pharmaceuticals, Inc. |
Induce and enhance immune responses using recombinant replicon systems
|
ES2926904T3
(es)
|
2019-04-11 |
2022-10-31 |
Btl Medical Solutions A S |
Dispositivo para el tratamiento estético de estructuras biológicas mediante radiofrecuencia y energía magnética
|
US20220233526A1
(en)
|
2019-06-18 |
2022-07-28 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
|
US20220305114A1
(en)
|
2019-06-18 |
2022-09-29 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and small molecule pdl1 or pd1 inhibitor
|
WO2020255013A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and capsid assembly modulators being amide derivatives
|
WO2020255042A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and a pyrimidine derivative
|
WO2020255009A2
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and anti-pd-1 antibody
|
WO2020255016A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
|
EP3986456A1
(de)
|
2019-06-18 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Company |
Kombination von hepatitis-b-virus(hbv)-impfstoffen und auf hbv abzielender rnai
|
WO2020255022A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and aminopyridine derivatives as hpk1 inhibitors
|
US20220305116A1
(en)
|
2019-06-18 |
2022-09-29 |
Janssen Sciences lreland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and capsid assembly modulators being sulfonamide derivatives
|
CA3140707A1
(en)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combination of hepatitis b virus (hbv) vaccines and quinazoline derivatives
|
WO2020255020A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pd-l1 inhibitors
|
CA3141323A1
(en)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Recombinant interleukin 12 construct and uses thereof
|
WO2020255035A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyrimidine derivatives
|
CN114630675A
(zh)
|
2019-06-18 |
2022-06-14 |
爱尔兰詹森科学公司 |
乙型肝炎病毒(hbv)疫苗和抗pd-1或抗pd-l1抗体的组合
|
WO2020255010A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of recombinant interleukin 12 construct and hepatitis b virus (hbv) vaccines
|
CA3141238A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Hepatitis b virus (hbv) vaccines and uses thereof
|
WO2020254876A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Virus-like particle delivery of hepatitis b virus (hbv) vaccines
|
US20220305115A1
(en)
|
2019-06-18 |
2022-09-29 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
JP2022536945A
(ja)
|
2019-06-18 |
2022-08-22 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
B型肝炎ウイルス(HBV)ワクチンおよびHBVを標的化するRNAiの組合せ
|
WO2020255019A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and a quinazoline derivative
|
WO2020255015A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
|
EP3986563A1
(de)
|
2019-06-20 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Company |
Lipidnanopartikel oder liposomenabgabe von hepatitis-b-virus-(hbv)-impfstoffen
|
WO2020255063A1
(en)
|
2019-06-20 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Carbohydrate nanocarrier delivery of hepatitis b virus (hbv) vaccines
|
MX2022013485A
(es)
|
2020-05-04 |
2022-11-30 |
Btl Healthcare Tech A S |
Dispositivo y metodo para el tratamiento sin atencion del paciente.
|
US11878167B2
(en)
|
2020-05-04 |
2024-01-23 |
Btl Healthcare Technologies A.S. |
Device and method for unattended treatment of a patient
|
EP4165183A1
(de)
|
2020-06-12 |
2023-04-19 |
University of Rochester |
Codierung und expression von ace-trnas
|
AU2021303478A1
(en)
|
2020-07-08 |
2023-02-16 |
Janssen Sciences Ireland Unlimited Company |
RNA replicon vaccines against HBV
|
TW202245809A
(zh)
|
2020-12-18 |
2022-12-01 |
美商詹森藥物公司 |
用於治療b型肝炎病毒感染之組合療法
|
EP4267740A1
(de)
|
2020-12-28 |
2023-11-01 |
Arcturus Therapeutics, Inc. |
Auf hbv abzielende transkriptionsaktivator-ähnliche effektornukleasen (talens)
|
US11896816B2
(en)
|
2021-11-03 |
2024-02-13 |
Btl Healthcare Technologies A.S. |
Device and method for unattended treatment of a patient
|
WO2023150753A1
(en)
|
2022-02-07 |
2023-08-10 |
University Of Rochester |
Optimized sequences for enhanced trna expression or/and nonsense mutation suppression
|
WO2023233290A1
(en)
|
2022-05-31 |
2023-12-07 |
Janssen Sciences Ireland Unlimited Company |
Rnai agents targeting pd-l1
|